Beck Bode LLC’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,771
Closed -$605K 104
2025
Q2
$605K Buy
5,771
+396
+7% +$37.5K 0.1% 67
2025
Q1
$475K Sell
5,375
-3,473
-39% -$356K 0.09% 79
2024
Q4
$849K Sell
8,848
-99
-1% -$9.22K 0.16% 73
2024
Q3
$732K Sell
8,947
-102
-1% -$7.87K 0.14% 81
2024
Q2
$780K Sell
9,049
-25,059
-73% -$2.02M 0.16% 84
2024
Q1
$2.78M Sell
34,108
-5,490
-14% -$429K 0.57% 50
2023
Q4
$2.63M Sell
39,598
-1,864
-4% -$129K 0.59% 54
2023
Q3
$3.03M Sell
41,462
-775
-2% -$52.4K 0.77% 44
2023
Q2
$2.66M Sell
42,237
-4,578
-10% -$265K 0.65% 53
2023
Q1
$2.75M Buy
46,815
+1,155
+3% +$70.1K 0.68% 51
2022
Q4
$2.81M Buy
45,660
+21,735
+91% +$1.46M 0.63% 55
2022
Q3
$1.61M Buy
23,925
+11,797
+97% +$747K 0.35% 73
2022
Q2
$745K Sell
12,128
-1,133
-9% -$72.6K 0.16% 106
2022
Q1
$894K Buy
+13,261
New +$716K 0.2% 76

Other funds holding HQY

Beck Bode LLC's HQY Position: Q3 2025 in Review

Beck Bode LLC sold out of HealthEquity (HQY) in Q3 2025, closing a stake of 5,771 shares — an estimated $605K sold.

Beck Bode LLC first reported a position in HQY in Q1 2022 and held it in 14 quarters. The position peaked at $3.03M in Q3 2023. 494 funds tracked by Wall St. Rank hold HQY as of Q3 2025.

  • Beck Bode LLC reported no remaining HealthEquity position as of Q3 2025 after selling out during the quarter.
  • Beck Bode LLC sold 5,771 HealthEquity shares in Q3 2025, an estimated $605K.
  • Beck Bode LLC first reported a position in HealthEquity in Q1 2022 and held it in 14 quarters.
  • Beck Bode LLC's HealthEquity position peaked at $3.03M in Q3 2023.
  • 494 funds tracked by Wall St. Rank held HealthEquity as of Q3 2025.

Based on Beck Bode LLC's 13F filing for Q3 2025, filed 14 Nov 2025.